CannaCor is a licensed producer of medical cannabis and cannabis by-products located in Lesotho, southern Africa. It is supported by a group of professional executives with extensive knowledge and understanding of the needs of the medical cannabis industry. Their economic activities are based on the recently approved production and export of cannabis and cannabis by-products which can be used for medicinal needs. A proud pioneer, they aim to incorporate only the latest and best technologies and will become a medical cannabis producer to supply cannabis flower and extract products to tens of thousands of patients, physicians, pharmacies, hospitals, governments and researchers on a global scale. They are constantly striving to improve their products and adhere to strict procedural and environmental protocols in order to maximize purity, quality and customer satisfaction.
About CannaCor
- CannaCor (Pty) Ltd is an incorporated company under the Companies Act of 2011 in the Kingdom of Lesotho with Registration Number 65263 and TIN number 200084029-4.
- CannaCor is licensed as a prohibited drug operator. The license is granted under Section 12 of the Drug Abuse Act of 2008 with license number 02/D022/06-2019.
- CannaCor has obtained 50 000m2 of land in Berea, Lesotho, of which 30 000m2 is permitted for greenhouse or indoor cultivation of Cannabis.
- CannaCor intends to commence with the development of an aquaponics production facility for medical cannabis during the fourth quarter of 2019.
- The company will be able to serve Canada, Europe and other global markets from this facility.
- The Cannacor team will ensure that they are compliant with every aspect of the act and are certified by the following: ISO 9001, Good Agricultural and Collecting Practice (GACP), Good Manufacturing Practice (GMP) and Good Laboratory Practice (GLP).
Vision
The vision of CannaCor is to become a frontrunner of medical cannabis cultivation in Lesotho. Our focus is to implement sustainable production facilities and expand our lead with an aquaponics production plant while integrating all our management systems with a selection of blockchain technologies to ensure transparency, immutability and real-life tracking
Mission
CannaCor works with a group of experienced scientists, blockchain developers, pharmacists and engineers daily, with the goal of improving our company by researching and delivering environmentally sustainable high-quality cannabis products.
HOW DOES IT WORK?
The vision of CannaCor is to become a frontrunner of medical cannabis cultivation in Lesotho. Our focus is to implement sustainable production facilities and expand our lead with an aquaponics production plant while integrating all our management systems with a selection of blockchain technologies to ensure transparency, immutability and real-life tracking
Mission
CannaCor works with a group of experienced scientists, blockchain developers, pharmacists and engineers daily, with the goal of improving our company by researching and delivering environmentally sustainable high-quality cannabis products.
HOW DOES IT WORK?
- The CannaCor coin is created on the Ethereum network.
- The CannaCor cryptocurrency is sold to the public by means of ICO.
- Funds raised during the ICO will be used to build the cultivation facility and to develop the blockchain and its applications.
- Coins will be distributed to participants within 30 days after the ICO.
- Accepted currencies to buy the Cannacor Coin are Bitcoin (BTC), Ethereum (ETH) and Ripple (XRP).
Blockchain Track and Trace Features
The Blockchain provides the utmost transparency in the decentralized recording of data and ensures the records of the platform is secure, transparent, verifiable and immutable.
- Cannabis Cultivation cycle ManagementThe blockchain and applications will be used to coordinate the activities required to accept raw materials, manufacture the product, test for quality, package for shipping and schedule for delivery. Our aim is to measure and capture the quality of our products, production output and worker productivity to ensure the enterprise creates products that meet quality standards.
- Cannabis Supply Chain ManagementSupply chain management is the handling of the entire production flow of the CannaCor products — starting from seed planting all the way to delivering the final product to the consumer. To accomplish this task, CannaCor will create a network of processes that moves the product along from the suppliers of raw materials to the organizations which deal directly with users
- Regulatory and Compliance ManagementRegulators require detailed information regarding a medical cannabis cultivator’s business: where the product comes from, the results of any testing that has been done, the specified amount produced, and distribution. Our aim is to establish support processes to monitor information throughout the supply chain and ensure compliance with all regulations
The intention is to establish a facility where standardized, uniform and consistent products can be cultivated, without the use of pesticides, so that the content of the active ingredients is the same for each harvesting and processing stage. The development of the cultivation premises into a complete facility for the cultivation and production of medical cannabis is expected to commence in the fourth quarter of 2019.
The Aquaponics cultivation facility will be established to cultivate cannabis and produce products such as:
- Tetrahydrocannabinol (THC), Cannabidiol (CBD), Cannabinoids (CBN) and
- Tetrahydrocannabinol Acid (THCA) in various strengths and combinations.
- Extracts
- Oils
- Dried cannabis
- Oil capsules
The cannabis industry requires a technology infrastructure to support and improve the multistage cultivation process of cannabis. CannaCor has identified three major areas which need to be addressed.
- Process and cost analysis
- Genealogy tracking and optimization
Cannacor aims to ensure that the cannabis is produced:
- hygienically to keep microbiological contamination to a minimum so as to mitigate the negative effects during cultivation, processing and storage.
- under conditions that ensure the therapeutic properties of the end-product are constant and reproducible.
- under conditions that ensure that the therapeutic properties of the end-product are constant and reproducible.
- prove the organization’s management capabilities in product quality and safety assurance
- enable employees to develop good production and operation habits
- reduce safety risk in product quality
- timeously detect production and management problems to reduce costs
- ensure better understanding of and compliance with the relevant laws and regulations
- enhance the company’s international credibility and public image
- Increase customer’s long-term confidence in the enterprise.
- becoming a more consistent competitor
- meeting customer satisfaction needs
- increasing business opportunities by demonstrating compliance
- implementing more effective ways of working – saving time, money and resources
- less wastage
- motivating and engaging employees with efficient internal processes
- improving performance to reduce errors and increase the profit margin.
- Increased confidence in the reliability and trustworthiness of laboratory data
- Increased production of right first-time results
- Increased overall productivity
- Better laboratory reputation
- Reduced need for rework
- Reduced time spent on non-revenue earning investigations.
Currently cultivators struggle to produce a harvest of consistent quantity and quality by following repeated processes. In order to improve this aspect of cultivation, our system will track a batch and capture all information pertaining to its genealogy, exact amount of water and nutrients used, the precise pH, temperature and humidity at each stage of the batch’s cultivation process.
Supply Chain Management
CannaCor will create a network of processes that moves the product along from the suppliers of raw materials to the organizations which deal directly with users. The three major steps in the supply chain blockchain process are as follows:
Decentralized data record
Blockchain technology provides the utmost transparency in the decentralized recording of data. It ensures the supply chain record is secure, transparent, verifiable and immutable.
Packaging By integrating blockchain technology into packaging, the CannaCor team and its affiliates (retailers, shop owners, etc.) will be able to track the precise real-world movement of their cannabis inventory on an individual shipment basis. When a product is scanned, no data needs to be entered.
QR code scanning The company will make use of tracking technology which can communicate with modern smartphones, making implementation of this system simple for producers, retailers and consumers alike.
About Blockchain Corporation
The Blockchain Corporation team is committed to solving problems in the medical cannabis industry and focusing attention on implementing real-world blockchain technology solutions to ensure consistent crop growth of excellent quality and quantity. It aspires to streamline the cultivation life cycle of the cannabis crop and deliver pinpoint supply chain solutions to enhance product trace ability.
Blockchain Corporation will do this by positioning itself as an early adopter and implementer of a combination of Blockchain and Hyperledger technologies to manage the medical cannabis production life cycle and supply chain. Key focus areas are cultivation life cycle management and supply chain management.
- Stable valueThe CannaCor coin has the potential to become a cryptocurrency with a stable value and low volatility, while retaining all the appealing features of other cryptocurrencies.
- Secure cross-border transactionsThe CannaCor coin is an effective vehicle to ensure simple and secure transactions between CannaCor, suppliers and clients.
- Sustainability
- Growth rate
- Water use
Coin Buyback and Burn
CannaCor (Pty) Ltd will allocate 12% of its NETT profit to buy back CANNACOR coins twice a year over a period of 10 years.
100% of coins bought back will be burnt/destroyed immediately after buyback.
This will maintain stable growth of the CannaCor Cryptocurrency
Decrease initial supply of the CannaCor cryptocurrency
And Create a stable store of value with low volatility.
The goal is to increase the cryptocurrency value and achieve mass adoption of the coin in the cannabis industry.
Pre-ICO sale Information
- Pre-Sale Starts: 11 Sept 2019 and ends 15 December 2019
- Pre-ICO: Coin Price $0.06
- Coin Ticker: CANO
- Coin TypeL: ERC20 Ethereum
- Number of coins for Pre-ICO: 468 Million
- Total Coin Supply: 1.5 Billion
- The CannaCor coin is created on the Ethereum network.
- The CannaCor cryptocurrency is sold to the public by means of ICO.
- Funds raised during the ICO will be used to build the cultivation facility and to develop the blockchain and its applications.
- Coins will be distributed to participants within 30 days after the ICO.
- Accepted currencies to buy the Cannacor Coin are Bitcoin (BTC), Ethereum (ETH) and Ripple (XRP).
- 78%: Coin Sale
- 07%: CannaCor Team
- 07%: Blockchain Corp Team
- 05%: Strategic Partnerships
- 03%: Bounty & Airdrop
\
- 30%: Cultivation
- 30%: Technology & Core
- 08%: Marketing & Business
- 05%: Admin
- 12%: Liquidity on Exchanges
- 05%: Legal
- 05%: Exchange Listing Fee
- 05%: Commissions & Fees
- 4th QUARTER 2018
Current technologies researched to establish the CannaCor cryptocurrency
Various blockchain technologies researched to manage the medical cannabis cultivation life cycle and supply chain management systems
Strategic alliances formed with blockchain developers, cultivators and pioneers in the cannabis industry
Company incorporated in Lesotho, southern Africa, to operate the following business activities:
– growing of drug and pharmaceutical crops
– wholesale and/or retail sale of pharmaceutical and medical goods.
- 1st QUARTER 2019
Environmental Impact Assessment (EIA) curated and submitted
Licence application lodged with the Drug Control Authorities in Lesotho to obtain:
– authorization for export and import of medical cannabis
– authorization to produce medical cannabis products.
- 2nd QUARTER 2019
Greenpaper development
Design of cannabis cultivation plant.
- 3rd QUARTER 2019
New website design / landing page
Wallets and user administration panel development
Greenpaper updated and new corporate identity incorporated
Pre-ICO round starts 11 September 2019 and ends 15 December 2019.
- 4th QUARTER 2019
Design of cultivation plant, testing laboratory and packaging plant finalised
Construction of cultivation facility
Blockchain and Hyperledger Fabric application development, incorporating QR code labelling, product traceability, drug authentication, production life cycle management and supply chain applications
New wallets and website release.
- 1st QUARTER 2020
First cannabis crops planted
Application integration of production cycles.
- 2nd QUARTER 2020
Cannacor Team
- Hugo: CEO
- Pieter-Jan: CFO
- Pieter: Operations Director
- Tobie: Legal Advisor
- Refiloe: HR
- Jan: Technical Advisor
- Seabata: Security
- Frik: Master Grower
- Gerhard: Founder
- Logan: Software Engineer
- Ankur: Technical Advisor
- Latha: Technical Advisor
- Willie: Cultivation Advisor
- Sergey: Blockchain and Software Advisor
- Adeniji: Advisor
- Deepanshu: Advisor
- Peter Cris Nabida: Advisor
- https://cannacor.io/
- https://cannacor.io/assets/cannacor_whitepaper.pdf
- https://www.facebook.com/cannacor/
- https://www.linkedin.com/company/canna-cor-pty-ltd
- https://twitter.com/canna_cor
- https://t.me/cannacor
- https://discordapp.com/invite/ep4Szdj
- https://medium.com/@CannaCor
Username : Ozie94
ETH : 0xDa2F65ea0ED1948576694e44b54637ebeCA22576
Sounds Good,
ReplyDeleteI like to read your blog. You shared a wonderful information about cannabinoid medicine. Thanks for sharing this amazing stuff.